175 related articles for article (PubMed ID: 36516649)
1. Smoking affects the association between cognitive impairment and P50 inhibition defects in patients with chronic schizophrenia: A case-control study.
Wang DM; Xia LY; Zhou HX; Tian Y; Dai QL; Xiu MH; Chen DC; Wang L; Zhang XY
Asian J Psychiatr; 2023 Jan; 79():103391. PubMed ID: 36516649
[TBL] [Abstract][Full Text] [Related]
2. P50 inhibition deficit in patients with chronic schizophrenia: Relationship with cognitive impairment of MATRICS consensus cognitive battery.
Xia L; Yuan L; Du XD; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Trihn TH; Alnatour OI; Chen D; Xiu M; Wang L; Yang M; Zhang XY
Schizophr Res; 2020 Jan; 215():105-112. PubMed ID: 31780341
[TBL] [Abstract][Full Text] [Related]
3. P50 sensory gating, cognitive deficits and depressive symptoms in first-episode antipsychotics-naïve schizophrenia.
Li S; Yu B; Wang D; Xia L; Wang L; Chen D; Xiu M; Zhang XY
J Affect Disord; 2023 Mar; 324():153-161. PubMed ID: 36587903
[TBL] [Abstract][Full Text] [Related]
4. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naïve schizophrenia.
Xia L; Wang D; Wei G; Wang J; Zhou H; Xu H; Tian Y; Dai Q; Xiu M; Chen D; Wang L; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110246. PubMed ID: 33453321
[TBL] [Abstract][Full Text] [Related]
5. Smoking, MATRICS consensus cognitive battery and P50 sensory gating in a Han Chinese population.
Tan SP; Jie-Feng Cui ; Fan FM; Zhao YL; Chen N; Fan HZ; Zhang JG; Wang YH; Yoon JH; Soares JC; Zou YZ; Zhang XY
Drug Alcohol Depend; 2014 Oct; 143():51-7. PubMed ID: 25124304
[TBL] [Abstract][Full Text] [Related]
6. Sex difference in association between cognitive and P50 deficits in patients with chronic schizophrenia.
Wang D; Xia L; Zhang Z; Camkurt MA; Issac A; Wu E; Xiu M; Chen D; Zhang XY
Arch Womens Ment Health; 2023 Dec; 26(6):793-801. PubMed ID: 37673838
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in P50 inhibition defects with psychopathology and cognition in patients with first-episode schizophrenia.
Xia L; Liu R; Zhou H; Tian Y; Dai Q; Xiu M; Chen D; Wang D; Zhang X
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110380. PubMed ID: 34111493
[TBL] [Abstract][Full Text] [Related]
8. Association of cognitive and P50 suppression deficits in chronic patients with schizophrenia.
Xia L; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Zhang G; Du X; Jia Q; Zhu X; Wang L; Tang W; Zhang XY
Clin Neurophysiol; 2020 Mar; 131(3):725-733. PubMed ID: 32000073
[TBL] [Abstract][Full Text] [Related]
9. P50 suppression deficits and psychopathology in Han Chinese patients with schizophrenia.
Zhu XL; Tan SP; Wang ZR; Zhang JG; Li D; Fan FM; Zhao YL; Zou YZ; Tan YL; Yang F; Zhang XY
Neurosci Lett; 2017 Jul; 653():346-350. PubMed ID: 28606770
[TBL] [Abstract][Full Text] [Related]
10. Association of P50 with social function, but not with cognition in patients with first-episode schizophrenia.
Wang D; Xia L; Zhang Z; Guo J; Tian Y; Zhou H; Xiu M; Chen D; Zhang XY
Eur Arch Psychiatry Clin Neurosci; 2023 Nov; ():. PubMed ID: 37966511
[TBL] [Abstract][Full Text] [Related]
11. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
[TBL] [Abstract][Full Text] [Related]
12. P50 inhibition defects, psychopathology and gray matter volume in patients with first-episode drug-naive schizophrenia.
Lang X; Wang D; Zhou H; Wang L; Kosten TR; Zhang XY
Asian J Psychiatr; 2023 Feb; 80():103421. PubMed ID: 36563611
[TBL] [Abstract][Full Text] [Related]
13. P50, N100, and P200 Auditory Sensory Gating Deficits in Schizophrenia Patients.
Shen CL; Chou TL; Lai WS; Hsieh MH; Liu CC; Liu CM; Hwu HG
Front Psychiatry; 2020; 11():868. PubMed ID: 33192632
[TBL] [Abstract][Full Text] [Related]
14. [Sensory gating P50 in schizophrenic patients with and without homicide].
Wang HX; Zhen WF; Ma X; Wang YP; Tian JH; Dou QS; Zhao HX
Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2616-20. PubMed ID: 20137678
[TBL] [Abstract][Full Text] [Related]
15. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
[TBL] [Abstract][Full Text] [Related]
16. Combining CDP-choline and galantamine: Effects of a selective α7 nicotinic acetylcholine receptor agonist strategy on P50 sensory gating of speech sounds in healthy volunteers.
Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Illivitsky V; Knott V
J Psychopharmacol; 2019 Jun; 33(6):688-699. PubMed ID: 30920339
[TBL] [Abstract][Full Text] [Related]
17. Sensory Gating Deficits and their Clinical Correlates in Drug-Free/Drug-Naive Patients with Schizophrenia.
Karkal R; Goyal N; Tikka SK; Khanande RV; Kakunje A; Khess CRJ
Indian J Psychol Med; 2018; 40(3):247-256. PubMed ID: 29875532
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological correlates of P50 sensory gating in patients with schizophrenia.
Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MÁ; Soria C; Arango C
Schizophr Res; 2013 Jan; 143(1):102-6. PubMed ID: 23148896
[TBL] [Abstract][Full Text] [Related]
19. The Auditory P50 Gating in Mild Cognitive Impairment: A Case-Control Study.
Song W; Hu X; Xie G; Lai W; Wang Y; Wu D
Am J Alzheimers Dis Other Demen; 2022; 37():15333175211068966. PubMed ID: 35025693
[No Abstract] [Full Text] [Related]
20. One-day tropisetron treatment improves cognitive deficits and P50 inhibition deficits in schizophrenia.
Xia L; Liu L; Hong X; Wang D; Wei G; Wang J; Zhou H; Xu H; Tian Y; Dai Q; Wu HE; Chang C; Wang L; Kosten TR; Zhang XY
Neuropsychopharmacology; 2020 Jul; 45(8):1362-1368. PubMed ID: 32349117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
